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Polycystic kidney and liver disease and corticosterone changes. Mice
homozygous for the mutation cpk develop a lethal infantile polycystic
kidney disease (PKD) and have abnormal elevations of corticosterone
in the postnatal period. We examined the development of these elevated
glucocorticoid levels in early life. The histological progression of a
cystic lesion of the biliary ducts in older heterozygotes was also
studied. Normal mice had low (<85 nmollliter) or undetectable (<36
nmol/liter) levels from the sixth to twelfth day of life. Corticosterone
levels were significantly higher in all homozygote (cpk/cpk) and some of
the normal sibs, who were presumed to be heterozygote (cpk/+) mice
compared to age—matched controls from day seven to 12. Corticoster-
one levels were similar from the fifteenth day.
A significant proportion of adult obligate heterozygotes from breed-
ing pairs were found to have focal areas of cystic dilatation of the biliary
ducts, in the absence of any renal abnormality. The incidence of this
lesion increased with age (10% at 150 days, 23% at 300 days, 29% at 450
days, 65% at >450 days of age). The livers of homozygote mice dying
in infancy, and control adult mice of the C57BLI6J background strain
were free of cysts. The finding of hepatic cysts is reminiscent of adult
type PKD. The cpk model thus supports the concept that the different
forms of PKD may represent varying expression of a similar gene
complex.
Despite being the third most common cause of chronic renal
failure, with an estimated cost to U.S.A. economy alone of
$150,000,000.00 [1], little is known of the etiology of polycystic
kidney disease (PKD) in all its forms. As the human forms are
usually well advanced at time of detection, the study of renal
cyst development relies heavily on animal models. In rabbits
and rodents, nephron differentiation begins prenatally and
continues in the metanephrogenic blastema for up to one month
postnatally. Exposure of newborn animals to pharmacologic
doses of some glucocorticoids will induce PKD [2]. Glucocor-
ticoid production is low in the immediate post natal period in
these animals and in normal mice this "stress non-responsive
period" usually lasts from birth to 12 to 14 days [3]. Our
previous data has suggested that PKD could arise in the
presence of a fetal genetic predisposition and abnormal gluco-
corticoid metabolism. Examination of the mutant mouse cpk,
which has a recessively inherited lethal PKD, revealed elevated
serum—corticosterone levels at 10 days of age in homozygotes,
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with a lesser elevation in some phenotypically normal siblings,
who we suspect to be heterozygotes, and low levels comparable
to control animals in the remainder [4].
In this study, we characterize the timing and magnitude of the
post-natal rise in corticosterone in offspring of obligate cpk
heterozygotes and the relationship with the development of
PKD. We also report the histological progression of renal and
hepatic cysts associated with this mutation from birth to 560
days of age.
Methods
Our parental (P1) generation of mice was a DBA/2J.CS7BL/
6J-cpk breeding pair, which was obtained through the Jackson
Laboratory (Bar Harbour, Maine, USA). A cpk breeding line
was established from this pair in the Animal Care Center of the
I.W.K. Hospital for Children. Offspring from breeding pairs
known to be heterozygous (because of homozygote offspring
from previous matings) were studied. Also studied were obli-
gate heterozygotes from our colony and control C57BL/6J
mice. All mice were housed under conditions outlined by the
Canadian Council of Animal Care. Ambient room temperature
was maintained at 21°C with a regulated 12 hour light/12 hour
dark cycle.
Homozygotes with PKD were readily identified phenotypi-
cally by their bilateral abdominal swellings after 10 days of age.
Kidney cysts from homozygotes were punctured and the fluid
aspirated with a 23 gauge needle. Sodium and potassium of the
cyst fluid was measured on a Corning Flame Photometer 430
(Corning Medical, Medfield, Massachusetts, USA) in an at-
tempt to localize the cysts to the proximal or distal nephron.
Phenotypically normal, and homozygous cpk offspring were
sacrificed at five to 20 days gestation and blood was obtained by
decapitation for corticosterone levels. Blood was similarly
obtained from control animals of the C57BL/6J strain, with
which mice of the original cpk mutant strain, including our P1
males were congenic. As well, we sacrificed older heterozygote
animals in our colony, and control CS7BL/6J, ranging in age
from 200 days of age to 560 days. Liver and kidney samples
were obtained from all animals for histologic examination and
fixed in Trump's solution, sectioned after paraffin embedding
and stained by hematoxylin and eosin. Kidney and liver sec-
tions were read by two separate observers who were unaware
of the phenotypic diagnosis. Presence or absence of cysts were
recorded.
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Fig. 1. Each bar represents meUn of duplicate determinations on a
variable number of animals (N, as shown in the bar). Standard errors
are based on log—transformed data. Values for homozygous cpk/cpk
animals that are significantly different (as determined by one—way
analysis of variance and 95% confidence intervals for the means of
log—transformed data) are indicated by asterisks. Symbols are: (0)
control; (•) noncystic siblings; (Z) homozygotes.
Serum corticosterone concentrations were studied by radio-
immunoassay (RIA) using RSL Kit No. 301 (Radioassay Sys-
tem Laboratories Incorporated, Carson, California, USA) on
coded samples. The antiserum has a specificity of 100 per cent
for corticosterone. The lowest detectable amount is 36 nmoll
liter. Blood samples were obtained between 10:30 and 11:30
a.m.
Results
At time of death, the kidneys of our homozygote cpk mice
were markedly enlarged and normal renal tissue was almost
totally replaced by cysts. Cystic changes were often so severe,
particularly in older mice, that identification of the involved
segment(s) of the nephron was impossible. In less advanced
areas the cysts involved both the proximal nephron and the
distal collecting ducts. Electrolyte analysis of cystic fluid
showed that the mean sodium level (21.9 7.5 mEqlliter, N =
15) was significantly lower (P = 0.001) than potassium (41.0
14.2 mEq/liter, N = 15), thus suggesting that the cysts origi-
nated in the distal nephron [51. Corticosterone levels during
days 7, 9 and 11 of life were significantly higher in cpk
homozygotes than in presumed heterozygotes (cpk/+) or con-
trols (+1+) (Fig. 1). The control animals had undetectable (<36
nmollliter) or low (<84 nmollliter) levels at five to 11 days of
age. Some non-cystic sibs of affected animals in this age group
had low levels. We suggest that these sibs were homozygous
normals. Other sibs, which we suggest were heterozygotes, had
values intermediate (15 percent had values greater than 100
nmollliter) between the homozygote mutants and the controls
on day nine. By 15 days of age the difference had disappeared.
The corticosterone levels of the adult obligate heterozygotes
used as breeding pairs and other C57BLI6J congenic mutants
were not different.
The adult obligate heterozygotes had focal areas of cystic
dilatation in the liver biliary ducts (Fig. 2). These cystic changes
increased with age. In heterozygotes (cpkl+) less than 150 days
old, the incidence of cysts was 10% (2 of 20); by 300 and 450
Fig. 2. A. Liver from a 550-day—old heterozygote mouse. Arrows
denote large cystic areas with connecting biliary ducts but numerous
small cysts in smaller ductules are also evident. B. Hematoxylin and
eosin section of the same liver X88.
days, the incidence rose to 26% (6 of 27) and 29% (10 of 36),
respectively. In mice older than 450 days, the majority (65%, 7
of 11) had cysts. There were no cysts in the liver of the
homozygous normal mice, or adult control C57BL/6J mice. We
could not examine adult affected homozygotes because they
had all died of renal failure by four weeks of age.
Discussion
In glucocorticoid—induced PKD, previous work has shown
that there is a "time window" in which steroids become
teratogenic (unpublished data). This "time window" is related
to nephron differentiation, as the steroids will not induce cysts
in mature nephrons. In the spontaneously occurring disease,
this window corresponds to the time when corticosterone
production would normally be very low or undetectable [3]. The
controlling mechanisms of both the susceptibility to PKD and
corticosterone production appear to be associated, at least in
the cpk/cpk mouse [4]. That the corticosterone levels are also
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elevated in heterozygotes suggests that the gene is pleiotropic,
acting as a dominant with respect to corticosterone levels.
It is appropriate to consider how the cpk gene might induce
cystic change. Three pathogenetic mechanisms for cyst forma-
tion have been proposed: (a) an increase in tubular cell prolif-
eration; (b) an alteration in tubular basement membrane pro-
duction and (c) extratubular or intratubular obstruction of the
nephron [6]. Recent organ culture experiments of Avner et al [7]
show that glucocorticoids induce cysts, presumably in the
absence of increased hydrostatic pressures. Another experi-
ment has demonstrated that the early proximal tubular changes
in this model regress when the organs are explanted to serum
free media, thus supporting the concept that a circulating factor
is involved in cyst pathogenesis [8]. The kidney in other species
has been identified as a highly steroid—sensitive organ, with
discrete mineralocorticoid and between one and three types of
glucocorticoid receptors. Variation in steroid receptor affinity
and number has been proposed as the modulating process of
steroid effect in other aspects of fetal development [9] and
teratogenesis [10]. Similar receptors may regulate different
processes in different tissues [11], and if the corticosterone—
PKD association represents a causal relationship, a change in
receptor status could provide the basis for both end organ
sensitivity and disruption of normal regulation of steroid pro-
duction. Preliminary data in our own laboratory using steroid
antagonists has shown amelioration in cyst development in the
cpklcpk mouse [12]
While uremic humans have elevated morning free—cortisols
[13], uremia does not account for our findings as the rise in
corticosterone in homozygotes also occurred in phenotypically
normal siblings. Also, after 15 days of age, when homozygotes
are uremic, their corticosterone levels do not differ from their
siblings or controls.
We regard our findings of cysts in the livers of adult
heterozygote cpk mice to be of central interest. It has generally
been accepted that liver cysts form from progressive segmen-
tation and dilation of Von Meyenberg's complexes [14]. The
complexes represent the remnants of intrahepatic bile ducts
which form in excess and do not establish any connection with
larger intralobular ducts. Located in the portal tracts under
normal conditions, these complexes involute and disappear.
Liver cysts do not generally communicate with the biliary tree,
and do not contain bile unless their growth causes rupture in the
adjacent bile ducts. The cyst fluid has been analyzed and is said
to resemble human bile with the bile salt fraction absent. We do
not know if the liver cysts in the cpk mice are communicating
with the biliary system and only future work will delineate this.
One can confirm, however, that hepatic fibrosis is not present.
Mandell et al [15] have emphasized the similarities between
the condition produced in mice by cpk, and the infantile form of
human PKD. In the infantile form of PKD, an autosomal
recessive condition, patients may develop kidney cysts any-
where along the nephron, but the majority are found in the
distal portion. They also develop progressive hepatic fibrosis
with or without obstructive cystic dilatations. More common is
the adult variety of PKD, which is inherited as an autosomal
dominant condition. Linkage of this gene locus with a highly
polymorphic DNA marker located on chromosome 16 has
recently been established [16]. In this form of PKD, the kidney
cysts are found both in the collecting ducts and proximal
nephron and retain the functional characteristics of the segment
of origin [17]. Forty percent of the adults with renal lesions have
hepatic cysts and the occurrence of liver cysts in the adult PKD
is age related [14]; relatives of these patients may have cystic
lesions of the liver without PKD [14]. Our finding of liver cysts
in the older heterozygotes is reminiscent of dominantly inher-
ited, adult human PKD.
We are led to conclude that the mouse mutant, cpk, shows
features that resemble both the infantile and the adult forms of
PKD in humans. The fact that cortocosterone levels are ele-
vated in the mutant homozygote mice for the same short period
of time that normal mice are susceptible to induction of PKD by
exogenous steroids indicates that a common pathogenetic
mechanism for PKD may be present.
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